• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    125.08 Up 0.03(0.02%) May 22, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 138,509   144,556   178,987   138,421  
    Cost of Revenue12,307  14,027  14,184  17,300  
    Gross Profit 126,202   130,529   164,803   121,121  
    Operating Expenses
    Research Development215,599  201,463  190,300  225,126  
    Selling General and Administrative85,860  78,527  75,224  77,446  
    Non Recurring(3,272)4,164  40,843  (270)
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (171,985) (153,625) (141,564) (181,181)
    Income from Continuing Operations
    Total Other Income/Expenses Net(5,113)(3,792)(3,990)37,731  
    Earnings Before Interest And Taxes(177,098)(157,417)(145,554)(143,450)
    Interest Expense21,307  21,177  20,384  15,585  
    Income Before Tax(198,405)(178,594)(165,938)(159,035)
    Income Tax Expense299  2,043  3,419  693  
    Minority Interest98  4,190   -   -  
    Net Income From Continuing Ops(198,704)(180,637)(169,357)(159,728)
    Non-recurring Events
    Discontinued Operations -  (209)(703)346  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (198,606) (176,656) (170,060) (159,382)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (198,606) (176,656) (170,060) (159,382)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.